Gut microbiome signature in response to neoadjuvant chemoradiotherapy in patients with rectal cancer

Gut microbiome signature in response to neoadjuvant chemoradiotherapy in patients with rectal cancer

BackgroundRectal cancer remains a leading cause of cancer-associated mortality, especially in advanced cases with limited treatment options. Emerging evidence suggests that the gut microbiome may influence the therapeutic efficacy of neoadjuvant chemoradiotherapy (CRT).ObjectiveThis study aimed to e...

Full description

Saved in:
Bibliographic Details
Main Authors: Tingmei Duan, Zhengting Ren, Haili Jiang, Yan Ding, Hongyan Wang, Fan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Microbiology
Subjects:
rectal cancer
neoadjuvant chemoradiotherapy (CRT)
gut microbiome
proteomics
16S rRNA sequencing
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1543507/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items